return2ozma to News · 1 year agoOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square158fedilinkarrow-up1618arrow-down117cross-posted to: [email protected][email protected][email protected][email protected]health
arrow-up1601arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comreturn2ozma to News · 1 year agomessage-square158fedilinkcross-posted to: [email protected][email protected][email protected][email protected]health
minus-squareMarcbmannlinkfedilinkarrow-up2·edit-21 year agoNovo Nordisk’s CEO was paid $9.8 million last year, inclusive of bonus and benefits.
Novo Nordisk’s CEO was paid $9.8 million last year, inclusive of bonus and benefits.